Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231
Molecules · 20.05.2024 · 29 (10) · 2400
DOI: 10.3390/molecules29102400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 20.05.2024. Verfasst von Denitsa Yancheva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., Build. 9, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Apoptosis, Breast Neoplasms, Hydrazones. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NATIONAL SCIENCE FUND OF BULGARIA.
Abstract (Originalsprache)
(1)
Background
The aim of the work is the evaluation of in vitro antiproliferative and pro-apoptotic activity of four benzimidazole derivatives containing colchicine-like and catechol-like moieties with methyl group substitution in the benzimidazole ring against highly invasive breast cancer cell line MDA-MB-231 and their related impairment of tubulin dynamics. (2)
Methods
The antiproliferative activity was assessed with the MTT assay. Alterations in tubulin polymerization were evaluated with an in vitro tubulin polymerization assay and a docking analysis. (3)
Results
All derivatives showed time-dependent cytotoxicity with IC50 varying from 40 to 60 μM after 48 h and between 13 and 20 μM after 72 h. Immunofluorescent and DAPI staining revealed the pro-apoptotic potential of benzimidazole derivatives and their effect on tubulin dynamics in living cells. Compound 5d prevented tubulin aggregation and blocked mitosis, highlighting the importance of the methyl group and the colchicine-like fragment. (4)
Conclusions
The benzimidazole derivatives demonstrated moderate cytotoxicity towards MDA-MB-231 by retarding the initial phase of tubulin polymerization. The derivative 5d containing a colchicine-like moiety and methyl group substitution in the benzimidazole ring showed potential as an antiproliferative agent and microtubule destabilizer by facilitating faster microtubule aggregation and disrupting cellular and nuclear integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev St., Build. 9, 1113 Sofia, Bulgaria.
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev St., Build. 21, 1113 Sofia, Bulgaria.
- Institute of Biodiversity and Ecosystem Research, Bulgarian Academy of Sciences, 2 Gagarin Str., 1113 Sofia, Bulgaria.
ORCID-Profile: Denitsa Yancheva, Irina Georgieva, Maya Guncheva, Nadezhda Todorova, Rumiana Tzoneva
Förderung
- NATIONAL SCIENCE FUND OF BULGARIA
Zitieren
APA
Yancheva, D., Argirova, M., Georgieva, I., Milanova, V., Guncheva, M., Rangelov, M., Todorova, N., & Tzoneva, R. (2024). Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231. Molecules, 29(10), 2400. https://doi.org/10.3390/molecules29102400
Vancouver
Yancheva D, Argirova M, Georgieva I, Milanova V, Guncheva M, Rangelov M, et al. Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231. Molecules. 2024;29(10):2400. doi:10.3390/molecules29102400
BibTeX
@article{Yancheva2024,
author = {Yancheva, Denitsa and Argirova, Maria and Georgieva, Irina and Milanova, Vanya and Guncheva, Maya and Rangelov, Miroslav and Todorova, Nadezhda and Tzoneva, Rumiana},
title = {Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231},
journal = {Molecules},
year = {2024},
volume = {29},
number = {10},
pages = {2400},
doi = {10.3390/molecules29102400}
}
EUVIMED